ALBERT DAVID
Back to Cashflow Statement
|
ALBERT DAVID Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹0.11 Cr | ₹-8.27 Cr | ₹-6.36 Cr | ₹-1.59 Cr | ₹-1.71 Cr |
What is the latest Cash Flow from Financing Activities ratio of ALBERT DAVID ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹0.11 Cr |
| Mar2024 | ₹-8.27 Cr |
| Mar2023 | ₹-6.36 Cr |
| Mar2022 | ₹-1.59 Cr |
| Mar2021 | ₹-1.71 Cr |
How is Cash Flow from Financing Activities of ALBERT DAVID Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.11 Cr | Positive | |
| Mar2024 | ₹-8.27 Cr | Negative | |
| Mar2023 | ₹-6.36 Cr | Negative | |
| Mar2022 | ₹-1.59 Cr | Negative | |
| Mar2021 | ₹-1.71 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ALBERT DAVID
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALBERT DAVID | ₹397.9 Cr | -2.4% | -4.1% | -16.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,792.0 Cr | 1.4% | 1.2% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,152.0 Cr | -0.5% | -0.6% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,915.0 Cr | 2.1% | 1.5% | 42.2% | Stock Analytics | |
| CIPLA | ₹116,354.0 Cr | 6.4% | 1.6% | -3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,681.0 Cr | 6.2% | 1.6% | 0.2% | Stock Analytics | |
ALBERT DAVID Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | -2.4% |
-4.1% |
-16.9% |
| SENSEX | -0.4% |
0.8% |
-5.3% |
You may also like the below Video Courses